相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Unannotated proteins expand the MHC-I-restricted immunopeptidome in cancer
Tamara Ouspenskaia et al.
NATURE BIOTECHNOLOGY (2022)
Identification of neoantigens for individualized therapeutic cancer vaccines
Franziska Lang et al.
NATURE REVIEWS DRUG DISCOVERY (2022)
Neoantigen-driven B cell and CD4 T follicular helper cell collaboration promotes anti-tumor CD8 T cell responses
Can Cui et al.
CELL (2021)
Personal neoantigen vaccines induce persistent memory T cell responses and epitope spreading in patients with melanoma
Zhuting Hu et al.
NATURE MEDICINE (2021)
Advances in the development of personalized neoantigen-based therapeutic cancer vaccines
Eryn Blass et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2021)
An Empirical Antigen Selection Method Identifies Neoantigens That Either Elicit Broad Antitumor T-cell Responses or Drive Tumor Growth
Hubert Lam et al.
CANCER DISCOVERY (2021)
mRNA therapeutics in cancer immunotherapy
Jan D. Beck et al.
MOLECULAR CANCER (2021)
A vaccine targeting mutant IDH1 in newly diagnosed glioma
Michael Platten et al.
NATURE (2021)
Personalized cancer vaccine strategy elicits polyfunctional T cells and demonstrates clinical benefits in ovarian cancer
Janos L. Tanyi et al.
NPJ VACCINES (2021)
Transcriptional programs of neoantigen-specific TIL in anti-PD-1-treated lung cancers
Justina X. Caushi et al.
NATURE (2021)
Phenotype, specificity and avidity of antitumour CD8+ T cells in melanoma
Giacomo Oliveira et al.
NATURE (2021)
High-throughput and single-cell T cell receptor sequencing technologies
Joy A. Pai et al.
NATURE METHODS (2021)
Neoantigen vaccination induces clinical and immunologic responses in non-small cell lung cancer patients harboring EGFR mutations
Fenge Li et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
Phase I/II trial of a long peptide vaccine (LPV7) plus toll-like receptor (TLR) agonists with or without incomplete Freund's adjuvant (IFA) for resected high-risk melanoma
Sapna P. Patel et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2021)
A machine learning model for ranking candidate HLA class I neoantigens based on known neoepitopes from multiple human tumor types
Jared J. Gartner et al.
NATURE CANCER (2021)
Combined Vaccination with NY-ESO-1 Protein, Poly-ICLC, and Montanide Improves Humoral and Cellular Immune Responses in Patients with High-Risk Melanoma
Anna Pavlick et al.
CANCER IMMUNOLOGY RESEARCH (2020)
T Cell Epitope Predictions
Bjoern Peters et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 38 (2020)
Mutation position is an important determinant for predicting cancer neoantigens
Aude-Helene Capietto et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2020)
A large peptidome dataset improves HLA class I epitope prediction across most of the human population
Siranush Sarkizova et al.
NATURE BIOTECHNOLOGY (2020)
Genome-wide CRISPR-Cas9 screening reveals ubiquitous T cell cancer targeting via the monomorphic MHC class I-related protein MR1
Michael D. Crowther et al.
NATURE IMMUNOLOGY (2020)
Computational Prediction and Validation of Tumor-Associated Neoantigens
Vladimir Roudko et al.
FRONTIERS IN IMMUNOLOGY (2020)
Integrated proteogenomic deep sequencing and analytics accurately identify non-canonical peptides in tumor immunopeptidomes
Chloe Chong et al.
NATURE COMMUNICATIONS (2020)
Improved Prediction of MHC II Antigen Presentation through Integration and Motif Deconvolution of Mass Spectrometry MHC Eluted Ligand Data
Birkir Reynisson et al.
JOURNAL OF PROTEOME RESEARCH (2020)
Vaccination against Nonmutated Neoantigens Induced in Recurrent and Future Tumors
Greta Garrido et al.
CANCER IMMUNOLOGY RESEARCH (2020)
A Frameshift Peptide Neoantigen-Based Vaccine for Mismatch Repair-Deficient Cancers: A Phase I/IIa Clinical Trial
Matthias Kloor et al.
CLINICAL CANCER RESEARCH (2020)
A Phase Ib Trial of Personalized Neoantigen Therapy Plus Anti-PD-1 in Patients with Advanced Melanoma, Non-small Cell Lung Cancer, or Bladder Cancer
Patrick A. Ott et al.
CELL (2020)
An RNA vaccine drives immunity in checkpoint-inhibitor-treated melanoma
Ugur Sahin et al.
NATURE (2020)
mRNA vaccine-induced neoantigen-specific T cell immunity in patients with gastrointestinal cancer
Gal Cafri et al.
JOURNAL OF CLINICAL INVESTIGATION (2020)
Shared Immunogenic Poly-Epitope Frameshift Mutations in Microsatellite Unstable Tumors
Vladimir Roudko et al.
CELL (2020)
Pembrolizumab plus GX-188E therapeutic DNA vaccine in patients with HPV-16-positive or HPV-18-positive advanced cervical cancer: interim results of a single-arm, phase 2 trial
Jin Won Youn et al.
LANCET ONCOLOGY (2020)
Integrative single-cell analysis
Tim Stuart et al.
NATURE REVIEWS GENETICS (2019)
Turning the corner on therapeutic cancer vaccines
Robert E. Hollingsworth et al.
NPJ VACCINES (2019)
Immunogenic neoantigens derived from gene fusions stimulate T cell responses
Wei Yang et al.
NATURE MEDICINE (2019)
Defining HLA-II Ligand Processing and Binding Rules with Mass Spectrometry Enhances Cancer Epitope Prediction
Jennifer G. Abelin et al.
IMMUNITY (2019)
MHC-II neoantigens shape tumour immunity and response to immunotherapy
Elise Alspach et al.
NATURE (2019)
Robust prediction of HLA class II epitopes by deep motif deconvolution of immunopeptidomes
Julien Racle et al.
NATURE BIOTECHNOLOGY (2019)
Cancer Neoantigens
Ton N. Schumacher et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 37, 2019 (2019)
Actively personalized vaccination trial for newly diagnosed glioblastoma
Norbert Hilf et al.
NATURE (2019)
Neoantigen vaccine generates intratumoral T cell responses in phase Ib glioblastoma trial
Derin B. Keskin et al.
NATURE (2019)
Deep learning using tumor HLA peptide mass spectrometry datasets improves neoantigen identification
Brendan Bulik-Sullivan et al.
NATURE BIOTECHNOLOGY (2019)
Features of effective T Cell-inducing vaccines against Chronic viral infections
Eleni Panagioti et al.
FRONTIERS IN IMMUNOLOGY (2018)
Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients
Andre Kahles et al.
CANCER CELL (2018)
RNA editing derived epitopes function as cancer antigens to elicit immune responses
Minying Zhang et al.
NATURE COMMUNICATIONS (2018)
Noncoding regions are the main source of targetable tumor-specific antigens
Celine M. Laumont et al.
SCIENCE TRANSLATIONAL MEDICINE (2018)
Mass Spectrometry Profiling of HLA-Associated Peptidomes in Mono-allelic Cells Enables More Accurate Epitope Prediction
Jennifer G. Abelin et al.
IMMUNITY (2017)
Insertion-and-deletion-derived tumour-specific neoantigens and the immunogenic phenotype: a pan-cancer analysis
Samra Turajlic et al.
LANCET ONCOLOGY (2017)
Personalized RNA mutanome vaccines mobilize poly-specific therapeutic immunity against cancer
Ugur Sahin et al.
NATURE (2017)
An immunogenic personal neoantigen vaccine for patients with melanoma
Patrick A. Ott et al.
NATURE (2017)
Systemic RNA delivery to dendritic cells exploits antiviral defence for cancer immunotherapy
Lena M. Kranz et al.
NATURE (2016)
Mutant MHC class II epitopes drive therapeutic immune responses to cancer
Sebastian Kreiter et al.
NATURE (2015)
A dendritic cell vaccine increases the breadth and diversity of melanoma neoantigen-specific T cells
Beatriz M. Carreno et al.
SCIENCE (2015)
Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy
Pierre G. Coulie et al.
NATURE REVIEWS CANCER (2014)
Mutational heterogeneity in cancer and the search for new cancer-associated genes
Michael S. Lawrence et al.
NATURE (2013)
Signatures of mutational processes in human cancer
Ludmil B. Alexandrov et al.
NATURE (2013)
分享论文
